Hydrochloric Acid

Hydrochloric Acid

SCHEMBL6680657

CN(C)CC(O)CCl.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1658052 0.97
Propane SCHEMBL8733413 0.95 CA1 (0.38)
SCHEMBL11229937 0.92 CA1 (0.39)
SCHEMBL8733411 0.87 HIF1A (0.36)
SCHEMBL8621185 0.87 HIF1A (0.36)
Acetic Acid SCHEMBL28227832 0.85 CA1 (0.35)
Hydrochloric Acid SCHEMBL10686188 0.84 HIF1A (0.43)
SCHEMBL9169483 0.82 CA1 (0.41)
SCHEMBL476608 0.81 DNM1 (0.40)
SCHEMBL22446645 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2774771-B1 PRE-TREATMENT LIQUID AND IMAGE FORMING METHOD RICOH CO LTD (JP) 2019-09-04 EP disclosed
US-9624129-B2 Inerting process for impurities LAFARGE (FR) 2017-04-18 US disclosed
US-9206329-B2 Pre-treatment liquid and image forming method RICOH COMPANY, LTD. (JP) 2015-12-08 US disclosed
US-20140253631-A1 PRE-TREATMENT LIQUID AND IMAGE FORMING METHOD RICOH COMPANY, LTD. (JP) 2014-09-11 US disclosed
EP-2774771-A2 Pre-treatment liquid and image forming method Ricoh Company, Ltd (JP) 2014-09-10 EP disclosed
US-20120216723-A1 INERTING PROCESS FOR IMPURITIES LAFARGE (FR) 2012-08-30 US disclosed
EP-1478800-A1 ANTI-MICROBIAL FABRIC TREATMENT HUNTSMAN INTERNATIONAL LLC (US) 2004-11-24 EP disclosed
CN-1133762-C Manufacture of improved recyclic cellulose fiber ��ʿ��֯��ʽ���� 2004-01-07 CN disclosed
WO-2003066957-A1 ANTI-MICROBIAL FABRIC TREATMENT HUNTSMAN INTERNATIONAL LLC (US) 2003-08-14 WO disclosed
CN-1300886-A Manufacture of improved recyclic cellulose fiber FUJI SPINNING CO LTD (JP) 2001-06-27 CN disclosed
US-6245117-B1 INCLUDING A HYDROCARBON GROUP, AN ALKANOLAMINE GROUP, AN AROMATIC GROUP AND/OR A POLYOXYALKYLENE ADDUCT; CROSSLINKING ON THE SURFACE OF THE CELLULOSE FIBER, ANTI-FIBRILLATION EFFECT AND DEEP DYEING EFFECT WITHOUT DAMAGING THE SOFTNESS IPPOSHA OIL INDUSTRIES CO., LTD. (JP) 2001-06-12 US disclosed
EP-0978585-A2 Modifier of cellulose fibers and modification method of cellulose fibers IPPOSHA OIL INDUSTRIES CO. LTD. (JP) 2000-02-09 EP disclosed
US-5731259-A REACTION WITH QUATERNARY AMMONIUM COMPOUND SOCIETA CONSORTILE RICERCHE ANGELINI S.P.A. (IT) 1998-03-24 US disclosed
EP-0582624-B1 CATIONIC POLYSACCHARIDES ANGELINI RICERCHE SPA (IT) 1997-07-02 EP disclosed